GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Semaglutide was associated with the strongest risk reduction. Epilepsy is an underrecognized ...

A new study published in the journal Neurology suggests that adults with type 2 diabetes who take the medication semaglutide might have a lower risk of developing seizures later in life. The research ...

Seizure disorders become increasingly common after the age of 60 years and can have a significant impact on functional status. The goal of antiepileptic drug therapy is to control seizures but ...

A new comparison of French and Swedish health records points to a sharper link than many doctors had previously tracked.

Because seizures in epilepsy can be unpredictable, you may experience persistent worry that affects your daily life and overall well-being. Practical strategies such as identifying your seizure ...

First-time seizures were associated with a higher relative risk of both neurologic and non-neurologic cancers within 1 year. Relative to the general population, the standardized incidence ratio was 76 ...